Table 2.
Demographic and clinical data
| Measure |
Group |
||||
|---|---|---|---|---|---|
| Left-affected participants (n = 91) | Right-affected participants (n = 63) | Control participants (n = 262) | |||
| Agea |
61(20, 89) |
62(21, 86) |
54.5(20, 89) |
||
| Sex (M/F) |
62/29 |
38/25 |
134/128 |
||
| Handedness(R/L/M) |
86/4/1 |
54/5/4 |
239/23/0 |
||
| Type of stroke(I/H) |
74/17 |
54/9 |
- |
||
| Stroke location (C/SC/C + SC/B/Cr/Cr + B)b |
36/24/23/4/3/1 |
28/20/9/6/0/0 |
- |
||
| Days since strokea |
15(2, 86) |
21(2, 85) |
- |
||
| BITa |
139(51, 146) |
141(58, 146) |
- |
||
| MoCAa,c |
24(13, 30) |
23(8, 29) |
- |
||
| FIM motor scorea |
70(17, 91) |
79(29, 91) |
- |
||
| FIM total scorea |
100(35, 126) |
107(43, 126) |
- |
||
| MAS leftd,e |
0.456(0, 3) |
0.016(0, 1) |
- |
||
| MAS rightd,f |
0.056(0, 1) |
0.429(0, 3) |
- |
||
| Limb |
Unaffected |
Affected |
Unaffected |
Affected |
- |
| CMSAa scoreg |
[0,0,0,0,7,23,61] |
[14,12,11,3,19,11,21] |
[0,0,0,0,2,15,46] |
[6-8,3,8,9,22] |
- |
| CMSAh scoreg | [0,0,0,0,0,28,63] | [15,9,6,6,21,22,12] | [0,0,0,0,2,23,38] | [6,5,5,5,12,12,18] | - |
Abbreviations:M/F, Male/female; R/L/M, Right/left/mixed; I/H, Ischemic/hemorrhagic; BIT, Behavioural Inattention Test; Mini-Mental Status Exam; MoCA, Montreal Cognitive Assessment; FIM, Functional Independence Measure; MAS, Modified Ashworth Score; CMSAh, Chedoke-McMaster Stroke Assessment – Impairment Scale hand; CMSAa, Chedoke-McMaster Stroke Assessment - Impairment Scale arm.
amedian value, minimum and maximum values in parentheses; bC/SC/C + SC/B/Cr/CR + B) represents: cortical/subcortical/cortical + subcortical/brainstem/cerebellar/ cerebellar + brainstem lesion location; cassessed in n = 83 left affected, 56 right affected; dmean value, minimum and maximum values in parentheses; en = 86 left affected, n = 61 right affected; fn = 90 left affected, n = 56 right affected; g[n1, n2, n3, n4, n5, n6, n7] represents number of participants with CMSA scores of [1-7].